Shares of Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) dropped 13.6% on Tuesday . The company traded as low as $2.73 and last traded at $2.73. Approximately 743 shares traded hands during trading, a decline of 73% from the average daily volume of 2,734 shares. The stock had previously closed at $3.16.
Relief Therapeutics Trading Down 13.6 %
The company’s fifty day moving average price is $3.76 and its 200-day moving average price is $4.44.
Relief Therapeutics Company Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Further Reading
- Five stocks we like better than Relief Therapeutics
- What is the NASDAQ Stock Exchange?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How Can Investors Benefit From After-Hours Trading
- 3 Must-Own Stocks to Build Wealth This Decade
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
